UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-05
DOI
10.1186/s12885-020-07225-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) Wui-Jin Koh et al. Journal of the National Comprehensive Cancer Network
- Risk factors for pelvic and distant recurrence in locally advanced cervical cancer
- (2019) Ana Carolina Matos Queiroz et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
- (2018) Femke M. de Man et al. CLINICAL PHARMACOKINETICS
- Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067)
- (2018) Maki Matoda et al. GYNECOLOGIC ONCOLOGY
- The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04)
- (2018) Jeanny Kwon et al. Cancer Research and Treatment
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer
- (2018) Yasuhiko Ebina et al. International Journal of Clinical Oncology
- Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010
- (2018) Satoru Nagase et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201)
- (2018) Taisuke Mori et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study
- (2017) Brandon-Luke L. Seagle et al. GYNECOLOGIC ONCOLOGY
- Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation
- (2017) Koji Matsuo et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical statistics of gynecologic cancers in Japan
- (2017) Wataru Yamagami et al. Journal of Gynecologic Oncology
- Germline genetic variants with implications for disease risk and therapeutic outcomes
- (2017) Amy L. Pasternak et al. PHYSIOLOGICAL GENOMICS
- Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum
- (2016) Masashi Takano et al. Asia-Pacific Journal of Clinical Oncology
- Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass
- (2016) Tadahiro Shoji et al. International Journal of Clinical Oncology
- Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy
- (2016) Munetaka Takekuma et al. International Journal of Clinical Oncology
- Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer
- (2016) Hisham A Abou-Taleb et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients
- (2015) Naoki Horikawa et al. BMC CANCER
- Cost of illness of the Cervical Cancer of the uterus in Japan - a time trend and future projections
- (2015) Eijiro Hayata et al. BMC HEALTH SERVICES RESEARCH
- Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting
- (2015) Phill-Seung Jung et al. PLoS One
- The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
- (2014) M M Dias et al. PHARMACOGENOMICS JOURNAL
- Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients
- (2013) Akira Hirasawa et al. JOURNAL OF HUMAN GENETICS
- Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)
- (2012) SATOSHI YAMAGUCHI et al. ONCOLOGY REPORTS
- UGT1A1predicts outcome in colorectal cancer treated with irinotecan and fluorouracil
- (2012) Yan Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer—Irinotecan and platinum chemotherapy
- (2010) Maki Matsumura et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started